GH

Guardant Health
NASDAQ
40.58
-1.44
-3.43%
After Hours: 40.40 -0.18 -0.44% 19:46 04/04 EDT
OPEN
39.70
PREV CLOSE
42.02
HIGH
42.16
LOW
39.14
VOLUME
1.89M
TURNOVER
--
52 WEEK HIGH
50.89
52 WEEK LOW
15.81
MARKET CAP
5.01B
P/E (TTM)
-11.4146
1D
5D
1M
3M
1Y
5Y
1D
GUARDANT HEALTH AND BAYSHORE HEALTHCARE PARTNER TO EXPAND ACCESS TO ADVANCED PRECISION ONCOLOGY TESTING IN CANADA
Reuters · 3d ago
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Barchart · 3d ago
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
NASDAQ · 5d ago
Weekly Report: what happened at GH last week (0324-0328)?
Weekly Report · 6d ago
abrdn Healthcare Opportunities Fund Q4 2024 Commentary
Seeking Alpha · 03/30 07:25
4 Healthcare Stocks With Massive Gains—and More to Come
Barchart · 03/29 06:15
Guardant Health’s Strategic Growth: Shield’s Coverage Expansion and Revenue Potential
TipRanks · 03/27 11:26
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Barchart · 03/27 06:06
More
About GH
More
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
Recently
Symbol
Price
%Change
    GH
  • 40.58
  • -3.43%

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.